SCHEMBL7811604

SCHEMBL7811604

CC(C)(Oc1ccccc1N1CCN(C(=O)c2ccncc2)CC1)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.66
TSHR P16473 4/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
LMNA P02545 3/20 0.57
POLB P06746 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.55
DRD2 P14416 1/20 0.52
HTR2A P28223 1/20 0.52
RBP4 P02753 1/20 0.51
TACR3 P29371 1/20 0.48
HTT P42858 2/20 0.48
PKM P14618 1/20 0.48
USP2 O75604 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
ALOX15 P16050 1/20 0.48
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813944 0.93 MEN1 (0.61) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7817763 0.89 KMT2A (0.61) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7810142 0.88 POLB (0.60) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7810154 0.88 MEN1 (0.60) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7810093 0.88 MEN1 (0.62) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7810164 0.87 MEN1 (0.58) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7814258 0.87 TSHR (0.61) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7813588 0.87 TSHR (0.58) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7810112 0.86 MEN1 (0.64) SMN1; SMN2TSHRMEN1KMT2ALMNA
SCHEMBL7813768 0.83 MEN1 (0.51) SMN1; SMN2TSHRMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed